| Purpose | Announcement Date | Ex-Date | Record Date | Dividend Amount | Dividend per Share | Remark |
|---|---|---|---|---|---|---|
| Dividend | 30 May 2025 | 22 Sep 2025 | 22 Sep 2025 | 0.4 | 40 | Final |
| Recommended the Final Dividend of ~0.40 Paise (Le., 40%) per equity share of face value of ~1/ each for the financial year 2024-25, subject to approval of the members at the ensuing Annual General Meeting (AGM). The AGM date and book closure / record date for the purpose of the payment of dividend will be informed in due course. Fixation of record date for determining the members eligible to receive dividend for the Financial Year 2024-25 (As Per BSE Announcement Dated on: 09/08/2025) | ||||||
| Dividend | 29 May 2024 | 23 Sep 2024 | 23 Sep 2024 | 0.4 | 40 | Final |
| Recommended the Dividend of Re.0.40 Paise (40%) per equity share of face value of Rs.1/-each for the financial year 2023-24, subject to approval of the members at the ensuing Annual General Meeting (AGM). The AGM date and book closure / record date for the purpose of the payment of dividend will be informed in due course | ||||||
For the June quarter, SMS Pharma reported a 24.3% year-on-year jump in net profit to ₹20.49 crore, compared with ₹16.48 crore a year earlier.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
